European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

Keywords

Library science, Medicine, Thyroid cancer, Thyroid carcinoma, Thyroid

References

• Sensitivity and specificity of the fine needle aspiration biopsy of the thyroid: clinical point of viewElizabeth Traver, Sergi Meseguer, Pablo Vargas Herrera Juan — 1999
• Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?Michael Snyder — 2000
• Bone Metastases from Thyroid Carcinoma: Clinical Characteristics and Prognostic Variables in One Hundred Forty-Six Patients大介 黒瀬, 成人 古屋, R. H. Shaw — 2000
• Chemotherapy in Metastatic Nonanaplastic Thyroid Cancer: Experience at the Institut Gustave-RoussyJean‐Pierre Droz, Martin Schlumberger, Philippe Rougier — 1990
• Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996Scott A. Hundahl, Blake Cady, Myles P. Cunningham — 2000
• Differentiated thyroid cancer long-term impact of initial therapy.Ernest L. Mazzaferri, Sissy Jhiang — 1995
• The prognostic value of primary tumor size in papillary and follicular thyroid carcinomaAndreas Machens, Hans‐Jürgen Holzhausen, Henning Dralle — 2005
• Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group.National Thyroid Cancer Treatment Cooperative Study Registr Group, Steven I. Sherman, James D. Brierley — 1998
• Human thyroglobulin reference material (CRM 457). 1st Part: Assessment of homogeneity, stability and immunoreactivity.Ulla Feldt‐Rasmussen, Christos Profilis, E Colinet — 1996
• Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.Ian Hay, Erik J. Bergstralh, John R. Goellner — 1993
• Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy.William H. Beierwaltes, Ronald H. Nishiyama, N W Thompson — 1982
• Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?Kunihiro Nakada, Tetsuya Ishibashi, Toshiki Takei — 2005
• Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.Michael Laßmann, Markus Luster, Heribert Hänscheid — 2004
• A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.Ernest L. Mazzaferri, Richard J. Robbins, Carole A. Spencer — 2003
• Prognostic importance of vascular invasion in papillary thyroid carcinoma.Richard E. Gardner, R. Michael Tuttle, Kenneth D. Burman — 2000
• 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study.Claudia Ceccarelli, W. Bencivelli, D Morciano — 2001
• The effect of 131 I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma.Robert D. Leeper — 1973
• Long‐term follow‐up of patients with bone metastases from differentiated thyroid carcinoma – surgery or conventional therapy?Georg Zettinig, Barbara J. Fueger, Christian Passler — 2002
• Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group.Patricia Niccoli, N. Wion-Barbot, Philippe Caron — 1997
• Report of the consensus development conference on the management of differentiated thyroid cancer in the NetherlandsCornelis J.�H. van de Velde, Jaap F. Hamming, B. M. Goslings — 1988

Cited by

• Central neck dissection in differentiated thyroid cancer: technical notesGioacchino Giugliano, Michele Proh, B Gibelli — 2014
• Disease control of differentiated thyroid carcinomas by hemithyroidectomy.Tam‐Lin Chow, Chul-Soon Choi, S H Lam — 2010
• Entfernung von Schilddrüse und NebenschilddrüsenU. Woenckhaus, R. Büttner, Leo Cornelius Bollheimer — 2007
• Therapeutic strategy of papillary microcarcinoma of the thyroid gland: a nuclear medicine perspective.Otmar Schober, Burkhard Riemann — 2009
• Management of low-risk differentiated thyroid cancer.Ernest L. Mazzaferri — 2007
• The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I昌広 中臣 — 2009
• Prognostic factors for differentiated thyroid carcinoma and review of the literature.Yuan Zhao, Yang Zhang, Xing‐Jun Liu — 2012
• Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone基子 渡邊 — 2009
• Papillary cancer nodal surgery and the advisability of prophylactic central neck dissection: primum, non nocere.G. Randolph — 2010
• Treatment of thyroid cancer with the new oral agents.Juan José Coy Ferrer — 2011
• Evaluation of thyroid nodules – combined use of 99mTc‐methylisobutylnitrile scintigraphy and aspiration cytology to assess risk of malignancy and stratify patients for surgical or nonsurgical therapy – a retrospective cohort studyBenedikt Westermann, Lars Fischer, Dang Vinh Pam — 2012
• Radioiodine treatment of well-differentiated thyroid cancerMark T. Jones, Paul E. Plassmann — 2012
• Thyroid Nodules in Pediatrics: Which Ones Can Be Left Alone, Which Ones Must be Investigated, When and HowRafael Muñiz González — 2012
• Not-So-Random Errors: Randomized Controlled Trials Are Not the Only Evidence of the Value of PETKarl A. Stiles — 2012
• Autophagy, a novel target for chemotherapeutic intervention of thyroid cancerSilvia Pino, Viviana Alejandra Mozzi, María De Los Ángeles Córdoba — 2014
• [Differentiated thyroid cancer].Linda Knox — 2015
• PRACTICAL BARRIERS TO IMPLEMENTATION OF THYROID CANCER GUIDELINES IN THE ASIA-PACIFIC REGION.Samantha Peiling Yang, Lee Suat Ying, Stephanie P.L. Saw — 2015
• Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative 124I-NaI-PET/CT in patients with papillary thyroid cancerM. Nigam, Sartaj Sahni, Balaji Krishnamurthy — 2016
• Papillary Thyroid Carcinoma Treated with Radiofrequency Ablation in a Patient with Hypertrophic Cardiomyopathy: A Case ReportM.C. Osborne, M.R. Midgett — 2016
• The utility of the Bethesda category and its association with BRAF mutation in the prediction of papillary thyroid cancer stageKelly L. Matson — 2017

Related papers

• The effect of fasting on tissue cyclic cAMP and plasma glucagon in the obese hyperglycemic mouse.Roanna Vine, Nancy R. Voyles, Pasqual V. Perrino — 1975
• Exogenous glucocorticoids and a high-fat diet cause severe hyperglycemia and hyperinsulinemia and limit islet glucose responsiveness in young male Sprague-Dawley rats.Jacqueline L. Beaudry, Anna M. D'souza, Trevor Teich — 2013
• Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.Ramin Alemzadeh, Kathryn Tushaus — 2004
• Growth hormone binding protein in the rat: effects of gonadal steroids.Danielle Carmignac, Britt G. Gabrielsson, Iain C.A.F. Robinson — 1993
• Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.E. FRAZE, C. C. Donner, Arthur Swislocki — 1985
• Anterior pituitary type II thyroxine 5'-deiodinase activity is not affected by lesions of the hypothalamic paraventricular nucleus which profoundly depress pituitary thyrotropin secretion.MASAMI MURAKAMI, Kiyoshi Tanaka, Monte A. Greer — 1988
• Cortistatin Is a Key Factor Regulating the Sex-Dependent Response of the GH and Stress Axes to Fasting in Mice.José Córdoba‐Chacón, Manuel D. Gahete, Ana I. Pozo-Salas — 2016
• Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance.Julio E. Ayala, Deanna P. Bracy, Freyja D. James — 2010
• The impact of euglycemia and hyperglycemia on stimulated pituitary hormone release in insulin-dependent diabetics.H. Vierhapper, Beatrix Grubeck‐Loebenstein, P. Bratusch-Marrain — 1981